Key Record Dates
| ClinicalTrials.gov Identifier: | NCT01140347 |
|---|---|
| Brief Title: | A Study of Ramucirumab (IMC-1121B) Drug Product (DP) and Best Supportive Care (BSC) Versus Placebo and BSC as 2nd-Line Treatment in Participants With Hepatocellular Carcinoma After 1st-Line Therapy With Sorafenib (REACH) |
| First Submitted : | June 2, 2010 |
| First Submitted that Met QC Criteria : | June 8, 2010 |
| First Posted : | June 9, 2010 (Estimate) |
| Results First Submitted : | March 13, 2015 |
| Results First Submitted that Met QC Criteria : | March 13, 2015 |
| Results First Posted : | March 26, 2015 (Estimate) |
| Certification/Extension First Submitted : | July 29, 2010 |
| Certification/Extension First Submitted that Met QC Criteria : | August 19, 2010 |
| Certification/Extension First Posted : | August 23, 2010 (Estimate) |
| Last Update Submitted that Met QC Criteria : | November 24, 2015 |
| Last Update Posted : | December 28, 2015 (Estimate) |